Uploaded November 2026 | Updated November 2026, 3 hours ago
Retatrutide vs Ozempic: Eli Lilly's triple agonist doubled the weight loss in a head-to-head trial, and 7.9% quit on the top dose. Both are true. Here is the fine print.
In this video I walk through what the TRANSCEND-T2D-2 trial actually found, what the headlines leave out, what it could mean if you have type 2 diabetes, and the one big question nobody can answer yet.
KEY NUMBERS (80 weeks, company-reported topline)
A1C drop: 2.2 points on retatrutide (9 mg and 12 mg) vs 1.8 on Ozempic 2 mg
Weight loss: 19.5% (9 mg) and 20.9% (12 mg) vs 9.4% on Ozempic
Stopped treatment due to side effects: 7.9% (retatrutide 12 mg) vs 2.7% (Ozempic)
CHAPTERS
00:00 Open
00:36 The Setup
02:08 Blood Sugar Results
03:18 Weight Loss Results
04:36 The Trade-Off
06:10 How Much Weight to Put on This
08:13 If You Have Type 2 Diabetes
09:07 Retatrutide vs Tirzepatide: What We Still Don't Know
10:08 Wrap
SOURCES
Eli Lilly topline announcement, Oct 28, 2026: fiercebiotech.com/biotech/eli-lillys-retatrutide-tops-ozempic-phase-3-diabetes-showdown
These are topline, company-reported results. They are open-label and have not been peer-reviewed, and no journal paper exists yet.
This video is for education only and is not medical advice. Do not change your treatment on your own. Talk with your doctor or pharmacist about what is right for you.
=======================================================
Affiliate Links (I earn commission for qualifying purchases)
Gruns: grns.sjv.io/AgoLV7
========================================================
Social Links
TikTok: tiktok.com/@thee_rmz
Instagram: instagram.com/thee_rmz
========================================================
DISCLAIMER: No information provided here is to be construed as medical advice. Always consult with a licensed medical provider for medical advice.
#glp1 #Retatrutide #zepbound #mounjaro #weightloss #weightlossjourney #glp #tirzepatide #semaglutide #wegovy #ozempic #menshealth #beforeandafter #beforeandafterweightloss
Retatrutide vs Ozempic: Eli Lilly's triple agonist doubled the weight loss in a head-to-head trial, and 7.9% quit on the top dose. Both are true. Here is the fine print.
In this video I walk through what the TRANSCEND-T2D-2 trial actually found, what the headlines leave out, what it could mean if you have type 2 diabetes, and the one big question nobody can answer yet.
KEY NUMBERS (80 weeks, company-reported topline)
A1C drop: 2.2 points on retatrutide (9 mg and 12 mg) vs 1.8 on Ozempic 2 mg
Weight loss: 19.5% (9 mg) and 20.9% (12 mg) vs 9.4% on Ozempic
Stopped treatment due to side effects: 7.9% (retatrutide 12 mg) vs 2.7% (Ozempic)
CHAPTERS
00:00 Open
00:36 The Setup
02:08 Blood Sugar Results
03:18 Weight Loss Results
04:36 The Trade-Off
06:10 How Much Weight to Put on This
08:13 If You Have Type 2 Diabetes
09:07 Retatrutide vs Tirzepatide: What We Still Don't Know
10:08 Wrap
SOURCES
Eli Lilly topline announcement, Oct 28, 2026: fiercebiotech.com/biotech/eli-lillys-retatrutide-tops-ozempic-phase-3-diabetes-showdown
These are topline, company-reported results. They are open-label and have not been peer-reviewed, and no journal paper exists yet.
This video is for education only and is not medical advice. Do not change your treatment on your own. Talk with your doctor or pharmacist about what is right for you.
=======================================================
Affiliate Links (I earn commission for qualifying purchases)
Gruns: grns.sjv.io/AgoLV7
========================================================
Social Links
TikTok: tiktok.com/@thee_rmz
Instagram: instagram.com/thee_rmz
========================================================
DISCLAIMER: No information provided here is to be construed as medical advice. Always consult with a licensed medical provider for medical advice.
#glp1 #Retatrutide #zepbound #mounjaro #weightloss #weightlossjourney #glp #tirzepatide #semaglutide #wegovy #ozempic #menshealth #beforeandafter #beforeandafterweightloss










